DAMP Laden Extracellular Vesicles From the Airways of Patients With Severe SARS‐CoV‐2 Respiratory Infection Compromise Inflammation and Cellular Metabolism
Journal of Extracellular Vesicles · 2026-06 · 15 (6)
DOI: 10.1002/jev2.70288 ↗At a glance
Journal article in Journal of Extracellular Vesicles, published online on 2026-05-28. Written by April Rees and 14 co-authors. Institution: Institute of Life Science, Swansea University Medical School, Swansea, Wales, UK. Major MEDLINE topics: Extracellular Vesicles, COVID-19, Inflammation. 84 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council.
Abstract (original language)
Highly inflammatory mononuclear phagocytes (MNPs) cause tissue damage across the respiratory tract and other organs in response to infections such as SARS‐CoV‐2. Extracellular vesicles (EVs) can metabolically and phenotypically reprogram target cells, suggesting a potential role in COVID‐19 pathology. We hypothesised that EVs drive inflammatory changes in COVID‐19 and investigated their cargo and effects on MNPs. EVs and MNPs were isolated from matched peripheral blood and airways of ventilated patients with and without severe COVID‐19, alongside healthy volunteer blood samples. Characterisation was performed using flow cytometry, microscopy, transcriptomics, PCR, proteomics, mass spectrometry, and bioenergetic profiling. We found that airway EVs from severe COVID‐19 patients carried altered cargo, notably reduced miRNAs and enriched mitochondrial DNA and ATP, a difference absents in the circulation. These DAMP‐rich EVs impaired healthy MNP function, suppressing cytokine production (e.g., IL‐6, IFNα2), and inflammatory programs identified in the monocyte proteomic profile, while also disrupting oxidative phosphorylation—features matching airway MNPs in severe disease. Interaction of COVID‐19 airway EVs with monocytes was diminished and these EVs had altered phosphatidylcholine/ lysophosphatidylcholine content. Our findings reveal a distinct EV cargo that reprograms immune metabolism, identifying a novel immunomodulatory mechanism exploited by SARS‐CoV‐2.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Life Science, Swansea University Medical School, Swansea, Wales, UK.
- Physiotherapy, Morriston Hospital, Swansea Bay University Health Board, Swansea, Wales, UK.
- Cryo-EM Facility, School of Biological & Behavioural Sciences, Queen Mary University of London, England, London, UK.
ORCID profiles: April Rees, Jason Webber
Funding
- Medical Research Council
Cite
APA
Rees, A., Richards, O., Raikes, M. E., Chambers, M., Reed, S. G., Battle, C., Toghill, H., Newey, L., Joseph, T. J., An, H., Zhang, H., Perry, I., Webber, J., Jones, N., & Thornton, C. A. (2026). DAMP Laden Extracellular Vesicles From the Airways of Patients With Severe SARS‐CoV‐2 Respiratory Infection Compromise Inflammation and Cellular Metabolism. Journal of Extracellular Vesicles, 15(6). https://doi.org/10.1002/jev2.70288
Vancouver
Rees A, Richards O, Raikes ME, Chambers M, Reed SG, Battle C, et al. DAMP Laden Extracellular Vesicles From the Airways of Patients With Severe SARS‐CoV‐2 Respiratory Infection Compromise Inflammation and Cellular Metabolism. Journal of Extracellular Vesicles. 2026;15(6). doi:10.1002/jev2.70288
BibTeX
@article{Rees2026,
author = {Rees, April and Richards, Oliver and Raikes, Molly E and Chambers, Megan and Reed, Sophie G and Battle, Ceri and Toghill, Hannah and Newey, Luke and Joseph, Tyler J and An, Haiyan and Zhang, Hui and Perry, Iain and Webber, Jason and Jones, Nicholas and Thornton, Catherine A},
title = {DAMP Laden Extracellular Vesicles From the Airways of Patients With Severe SARS‐CoV‐2 Respiratory Infection Compromise Inflammation and Cellular Metabolism},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/jev2.70288}
}
EUVIMED